Funds holding Bristol-Myers Squibb Company
ISIN US1101221406 · United States · LEI HLYYNH7UQUORYSJQCN42
- Fund holders
- 3
- Of which ETFs
- 0 3 other funds
- Value held
- 1.1K $
- Share of capital
- 0.0 % of 2B shares on Jul 22, 2026
This issuer has other securities : Bristol-Myers Squibb Co (US1101221083)
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 7,675 | 891.8 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| JNL/DFA U.S. Core Equity Fund JNL Series Trust | 1,534 | 178.3 $ | 0.00 % | as of Mar 31, 2026 ↗ | |
| Wilmington Large-Cap Strategy Fund Wilmington Funds | 89 | 6.9 $ | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 3 | 0 | 9,298 | 0.0 % |
| 2026Q1 | 3 | 0 | 9,298 | 0.0 % |
| 2025Q4 | 3 | 0 | 9,298 | 0.0 % |
| 2025Q3 | 3 | 0 | 9,298 | 0.0 % |
| 2025Q2 | 3 | 0 | 9,298 | 0.0 % |
| 2025Q1 | 3 | 0 | 9,298 | 0.0 % |
| 2024Q4 | 3 | 0 | 9,298 | 0.0 % |
| 2024Q3 | 3 | 0 | 9,298 | 0.0 % |
| 2024Q2 | 3 | +2 | 9,298 | +10,347.2 % |
| 2024Q1 | 1 | 0 | 89 | 0.0 % |
| 2023Q4 | 1 | 89 |
Institutional managers
16 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| TRANSCEND CAPITAL ADVISORS, LLC | 109,175 | 12.7K $ | as of Mar 31, 2026 |
| DAVENPORT & Co LLC | 83,970 | 9.7K $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 50,284 | 5.8K $ | as of Mar 31, 2026 |
| Purkiss Capital Advisors LLC | 26,450 | 3.1K $ | as of Mar 31, 2026 |
| FIFTH THIRD BANCORP | 20,000 | 2.3K $ | as of Mar 31, 2026 |
| TWO SIGMA SECURITIES, LLC | 16,227 | 1.9K $ | as of Mar 31, 2026 |
| Private Advisor Group, LLC | 15,000 | 1.7K $ | as of Mar 31, 2026 |
| UBS Group AG | 4,171 | 484 $ | as of Mar 31, 2026 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 341 | 39 $ | as of Mar 31, 2026 |
| ROTHSCHILD INVESTMENT LLC | 166 | 19 $ | as of Mar 31, 2026 |
| OAKWORTH CAPITAL, INC. | 125 | 14 $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 119 | 14 $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 23 | 3 $ | as of Mar 31, 2026 |
| Atlantic Edge Private Wealth Management, LLC | 16 | 2 $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 10 | 1 $ | as of Mar 31, 2026 |
| First Pacific Financial | 6 | 1 $ | as of Mar 31, 2026 |
Funds holding the debt of Bristol-Myers Squibb Company
336 funds declare 1,427 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Funds holding Bristol-Myers Squibb Company". https://titelia.com/en/stocks/bristol-myers-squibb-company-US1101221406